Therapeutic indications: TETADIF is used for specific prophylaxis against tetanus and diphtheria of person over 7 years of age and for post-exposure prophylaxis in person with recent injures that might be contaminated with tetanus spores and who did not receive prior vaccination or whose prior vaccination is uncompleted or unknown.

Active ingredient: Purified Tetanus and Diphtheria Toxoid

Posology and method of administration: The single dose of TETADIF is 0.5 ml. It is administered deep intramuscularly.

Nature and Contents of Container: Injectable suspension of 0.5 ml in ampoules.

Therapeutic indications: Reimmunization – of children over six years of age with 0.5 ml. When there are contraindications to pertussis component, diphtheria and tetanus vaccine is applied by the immunization schedule of DPT triple vaccine.

Active ingredient: Pürified diphtheria and tetanus toksoid

Posology and method of administration: The single dose of DIFTET is 0.5 ml.It is administered intramuscularly.

Nature and Contents of Container: Injectable suspension of 0.5 ml in ampoules.